Retrospective analysis assessed successful outcomes of robotic urological surgeries using KangDuo, suggesting safety and effectiveness with minimal complications.
Abstract Background To explore the clinical application of the three-arm KangDuo robot in urological surgeries. Methods The clinical data of 32 patients who underwent robot-assisted urological surgeries performed by the same surgeon between August 2023 and April 2024 were retrospectively analysed. Twenty of the patients underwent radical prostatectomy, 6 underwent partial nephrectomy, 2 underwent radical nephrectomy, 1 underwent radical cystectomy, 1 underwent pyeloplasty, 1 underwent a retroperitoneal mass resection, and 1 underwent residual ureteral cancer resection. Results All surgeries were successful, and no Clavien–Dindo grade III or higher complications occurred perioperatively. The median age of the patients was 70 (42–82) years. The median docking time was 7.2 (5.8–9.5) minutes. The median operation time was 132 (90–450) minutes. The median intraoperative blood loss volume was 100 (20–300) mL. The median postoperative hospital length of stay was 6 (3–13) days. Conclusions The three-arm KangDuo robot can be safely and effectively used in urological surgeries, but large-scale multicentre studies are needed for further verification.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: